Owners, management and financials
CVR: 38734164
Secondary names: SeedLabs ApS, BiOrigin ApS
Previous names: Bio Origin ApS, BiOrigin ApS
DKK 4,592,295
Gross profit
Net result: DKK -11,500,339
Novo Holdings A/S (100%)
CVR · view owners
Thomas Gundelund Rasmussen
Board: João Carlos Ribas de Almeida (chair) and 1 member
CVR · view management
Active
Founded 22 June 2017
CVR · view overview
4 employees
CVR · 2018
Director registered: Thomas Gundelund Rasmussen
CVR · 01/09/2025
View the full event history
de novo foundry ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2017. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The company was previously named BiOrigin ApS and Bio Origin ApS. The management consists of Thomas Gundelund Rasmussen. The board consists of João Carlos Ribas de Almeida (chair) and Gabor Gyulveszi. The company is owned by Novo Holdings A/S. The company has 4 employees (2018). In 2025, the company reported a gross profit of DKK 4,592,295 and a net result of DKK -11,500,339 compared with DKK -7,045,478 the year before. Equity in the 2025 report amounted to DKK 16,714,253.
Source: annual report 2025, Danish Business Authority
The financial health of de novo foundry ApS shows significant challenges, particularly with consistent losses over the past five years. Gross profit peaked at 8,695,015 DKK in 2024, but the company reported a notable loss of 11,500,339 DKK in 2025, indicating a declining trend in profitability. Despite these losses, equity remains relatively strong at 16,714,253 DKK, suggesting some resilience; however, the lack of disclosed revenue complicates the assessment of operational performance. The company operates in a competitive sector of scientific and technical services, but its financial trajectory raises concerns about sustainability and growth potential.
AI-generated summary · Generated 16/08/2026
Selskabets formål er at drive virksomhed med ydelse af konsulentbistand og rådgivning i forbindelse med investering i og drift af selskaber der arbejder med udvikling af lægemidler, medicinsk udstyr eller diagnostiske metode eller anden beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | - | -11.5 mio. | 23.1 mio. | 16.7 mio. | 12 | |
| 202401/01/2024 – 31/12/2024 | - | -7 mio. | 22.8 mio. | 18.2 mio. | 14 | |
| 202301/01/2023 – 31/12/2023 | - | -11.2 mio. | 14.6 mio. | 10.3 mio. | 13 | |
| 202201/01/2022 – 31/12/2022 | 5.8 mio. | -6 mio. | 13.5 mio. | 10.5 mio. | 6 | |
| 202101/01/2021 – 31/12/2021 | 2 mio. | -2.8 mio. | 7.8 mio. | 6.5 mio. | 3 | |
| 202001/01/2020 – 31/12/2020 | 1.7 mio. | -3.1 mio. | 11 mio. | 9.3 mio. | 4 | |
| 201901/01/2019 – 31/12/2019 | 1.2 mio. | -2.1 mio. | 6.5 mio. | 5.4 mio. | 2 | |
| 201801/01/2018 – 31/12/2018 | 1.1 mio. | -2.1 mio. | 4.3 mio. | 3.6 mio. | 1 |
Compared to 1.150 companies in Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of de novo foundry ApS is 38734164.
de novo foundry ApS is owned by Novo Holdings A/S.
The management of de novo foundry ApS consists of Thomas Gundelund Rasmussen.
The board of de novo foundry ApS consists of João Carlos Ribas de Almeida and Gabor Gyulveszi, with João Carlos Ribas de Almeida as chair.
In 2025, de novo foundry ApS reported a gross profit of DKK 4,592,295.
de novo foundry ApS had 4 employees in 2018 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
De novo foundry ApS has published its annual report for 2025. Gross profit came to DKK 4,592,295, and the net result was DKK -11,500,339.
As of September 1, 2025, Thomas Gundelund Rasmussen is registered as adm. dir. of de novo foundry ApS.
As of August 31, 2025, Søren Sylvester Skjærbæk has stepped down as adm. dir. of de novo foundry ApS.
As of July 1, 2025, João Carlos Ribas de Almeida has joined the board of directors of de novo foundry ApS.
As of July 1, 2025, Gabor Gyulveszi has joined the board of directors of de novo foundry ApS.
On July 1, 2025, the company changed its name from BiOrigin ApS to de novo foundry ApS.
As of June 30, 2025, Emmanuelle Coutanceau has left the board of directors of de novo foundry ApS.
As of June 30, 2025, João Carlos Ribas de Almeida has left the board of directors of de novo foundry ApS.
De novo foundry ApS has published its annual report for 2024. Gross profit came to DKK 8,695,015, and the net result was DKK -7,045,478.
As of February 1, 2025, João Carlos Ribas de Almeida has joined the board of directors of de novo foundry ApS.
As of February 1, 2025, Morten Døssing has left the board of directors of de novo foundry ApS.
As of August 30, 2024, Pieter Jeroen Bakker has left the board of directors of de novo foundry ApS.
De novo foundry ApS has published its annual report for 2023. Gross profit came to DKK 2,876,436, and the net result was DKK -11,228,030.
De novo foundry ApS has published its annual report for 2022. Revenue came to DKK 5,849,077, and the net result was DKK -6,017,830.
As of December 1, 2022, Søren Sylvester Skjærbæk is registered as adm. dir. of de novo foundry ApS.
As of December 1, 2022, Jakob Dynnes Hansen has stepped down as adm. dir. of de novo foundry ApS.
De novo foundry ApS has published its annual report for 2021. Revenue came to DKK 2,026,890, and the net result was DKK -2,829,711.
As of June 22, 2022, Morten Døssing has joined the board of directors of de novo foundry ApS.
De novo foundry ApS has published its annual report for 2020. Revenue came to DKK 1,651,840, and the net result was DKK -3,109,048.
De novo foundry ApS has published its annual report for 2019. Revenue came to DKK 1,159,899, and the net result was DKK -2,148,483.
As of September 16, 2019, Emmanuelle Coutanceau has joined the board of directors of de novo foundry ApS.
As of September 16, 2019, Pieter Jeroen Bakker has joined the board of directors of de novo foundry ApS.
As of September 16, 2019, Stephan Christgau has left the board of directors of de novo foundry ApS.
As of September 15, 2019, Emmanuelle Coutanceau has left the board of directors of de novo foundry ApS.
De novo foundry ApS has published its annual report for 2018. Revenue came to DKK 1,054,588, and the net result was DKK -2,094,816.
De novo foundry ApS has published its interim report for the period June 22, 2017 – December 31, 2017.
As of January 29, 2018, EY Godkendt Revisionspartnerselskab has been appointed auditor of de novo foundry ApS.
As of January 29, 2018, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of de novo foundry ApS.
On November 28, 2017, the company changed its name from Bio Origin ApS to BiOrigin ApS.
As of June 22, 2017, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of de novo foundry ApS.
As of June 22, 2017, Stephan Christgau has joined the board of directors of de novo foundry ApS.
As of June 22, 2017, Emmanuelle Coutanceau has joined the board of directors of de novo foundry ApS.
As of June 22, 2017, Jakob Dynnes Hansen is registered as adm. dir. of de novo foundry ApS.
As of June 22, 2017, Novo Holdings A/S is registered as an owner of de novo foundry ApS with an ownership share of 100%.
De novo foundry ApS was founded on June 22, 2017.
Companies in the same industry and area
CVR 43597760
CVR 44772531
CVR 28489455
CVR 42932876
CVR 46690796
